Mandibular advancement device (MAD) therapy is the most commonly used second-line
treatment for obstructive sleep apnea (OSA), but MAD may be ineffective in a subgroup of …

There is now widespread recognition within the world of sleep medicine of the increasing
importance of dental sleep medicine and, in particular, the role of oral appliance therapy …

Background Hypoxic burden (HB) has emerged as a strong predictor of cardiovascular risk
in obstructive sleep apnoea (OSA). We aimed to assess the potential of HB to predict the …

Many studies have shown an association of obstructive sleep apnea (OSA) with incident
cardiovascular diseases, particularly when comorbid with insomnia, excessive sleepiness …

Background Previous studies have identified a clinical association between gut microbiota
and Obstructive sleep apnea (OSA), but the potential causal relationship between the two …

Abstract Study Objectives Autonomic function is impaired in obstructive sleep apnea (OSA)
and may mediate the association between OSA and cardiovascular risk. We investigated the …

The aim of this systematic review and meta-analysis was to analyze whether or not
mandibular advancement devices (MADs) produce changes in blood pressure in patients …

Obstructive sleep apnea (OSA) is a common disorder characterized by recurrent upper
airway obstruction during sleep. Despite the availability of continuous positive airway …

With the purpose of establishing a consensus around clinical orientations for professionals
involved in managing patients with sleep breathing disorders (SBD), an interdisciplinary …

Summary We assessed:(1) the independent and joint association of obstructive sleep apnea
risk and healthy lifestyle with common consequences (excessive daytime sleepiness …